Upregulation of RGS7 may contribute to tumor necrosis factor-induced changes in central nervous function

Nature Medicine

Volumn 5, Issue 8, 1999, Pages 913-918

  Benzing, Thomas ^a   Brandes, Ralf ^b   Sellin, Lorenz ^a   Schermer, Bernhard ^a   Lecker, Stewart ^c   Walz, Gerd ^a   Kim, Emily ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; GUANINE NUCLEOTIDE BINDING PROTEIN; REGULATOR PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CYTOKINE PRODUCTION; ENZYME ACTIVATION; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STABILITY; SEPSIS;

EID: 0032780332     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/11354     Document Type: Article

References (33)

1. Haimovitz-Friedman, A. et al. Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation. J. Exp. Med. 186, 1831-1841 (1997).
2. Selby, P. et al. Tumour necrosis factor in man: clinical and biological observations. Br. J. Cancer 56, 803-808 (1987).
3. Waage, A., Brandtzaeg, P., Espevik, T. & Halstensen, A. Current understanding of the pathogenesis of gram-negative shock. Infect. Dis. Clin. North Am. 5, 781-791 (1991).
4. Remick, D.G. & Kunkel, S.L. Pathophysiologic alterations induced by tumor necrosis factor. Int. Rev. Exp. Pathol. 34, 7-25 (1993).
5. Kapas, L. et al. Somnogenic, pyrogenic, and anorectic activities of tumor necrosis factor-alpha and TNF-alpha fragments. Am. J. Physiol. 263, R708-715 (1992).
6. Dunn, A.J. & Swiergiel, A.H. The role of cytokines in infection-related behavior. Ann. NY Acad. Sci. 840, 577-85 (1998).
7. Fang, J., Wang, Y. & Krueger, J.M. Mice lacking the TNF 55 kDa receptor fail to sleep more after TNFalpha treatment. J. Neurosci. 17, 5949-5955 (1997).
8. Dohlman, H.G. & Thorner J. RGS proteins and signaling by heterotrimeric G proteins. J. Biol. Chem. 272, 3871-384 (1997).
9. Berman, D.M. & Gilman A.G. Mammalian RGS proteins: barbarians at the gate. J. Biol. Chem. 273, 1269-1272 (1998).
10. Kehrl, J.H. Heterotrimeric G protein signaling: roles in immune function and fine- tuning by RGS proteins. Immunity 8, 1-10 (1998).
11. Koelle, M.R. A new family of G-protein regulators - the RGS proteins. Curr. Opin. Cell Biol. 9, 143-147 (1997).
12. Koelle, M.R., Horvitz HR. EGL-10 regulates G protein signaling in the C. elegans nervous system and shares a conserved domain with many mammalian proteins. Cell 84, 115-125 (1996).
13. Gold, S.J., Ni, Y.G., Dohlman, H.G. & Nestler, E.J. Regulators of G-protein signaling (RGS) proteins: region-specific expression of nine subtypes in rat brain. J. Neurosci. 17, 8024-8037 (1997).
14. Wang, J. et al. RGSZ1, a Gz-selective RGS protein in brain. Structure, membrane association, regulation by galphaz phosphorylation, and relationship to a gz gt-pase-activating protein subfamily. J. Biol. Chem. 273, 26014-26025 (1998).
15. Glick, J.L., Meigs, T.E., Miron, A. & Casey, P.J. RGSZ1, a Gz-selective regulator of G protein signaling whose action is sensitive to the phosphorylation state of gzalpha. J. Biol. Chem. 273, 26008-26013 (1998).
16. Ingi, T. et al. Dynamic regulation of RGS2 suggests a novel mechanism in G-protein signaling and neuronal plasticity. J. Neurosci. 18, 7178-7188 (1998).
17. Shuey, D.J., Betty, M., Jones, P.G., Khawaja, X.Z. & Cockett, M.I. RGS7 attenuates signal transduction through the G(alpha q) family of heterotrimeric G proteins in mammalian cells. J. Neurochem. 70, 1964-1972 (1998).
18. Thomas, E.A., Danielson, P.E. & Sutcliffe, J.G. RGS9: a regulator of G-protein signalling with specific expression in rat and mouse striatum. J. Neurosci. Res. 52, 118-124 (1998).
19. Saugstad, J.A., Marino, M.J., Folk, J.A., Hepler, J.R. & Conn, P.J. RGS4 inhibits signaling by group I metabotropic glutamate receptors. J. Neurosci. 18, 905-913 (1998).
20. Kim, E. et al. Interaction between RGS7 and polycystin. Proc. Natl. Acad. Sci. USA 96, 6371-6376 (1999).
21. Aberle, H., Bauer, A., Stappert, J., Kispert, A. & Kemler, R. beta-catenin is a target for the ubiquitin-proteasome pathway. Embo. J. 16, 3797-3804 (1997).
22. Salomon, D. et al. Regulation of beta-catenin levels and localization by overexpression of plakoglobin and inhibition of the ubiquitin-proteasome system. J. Cell. Biol. 139, 1325-35 (1997).
23. Abu-Amer, Y., Ross, F.P., Edwards, J. & Teitelbaum, S.L. Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its PSS receptor. J. Clin. Invest. 100, 1557-1565 (1997).
24. He, W., Cowan, C.W. & Wensel, T.G. RGS9, a GTPase accelerator for phototransduction. Neuron 20, 95-102 (1998).
25. Khawaja, X.Z. et al. Immunohistochemical distribution of RGS7 protein and cellular selectivity in colocalizing with Galphaq proteins in the adult rat brain. J. Neurochem. 72, 174-184 (1999).
26. Segalat, L., Elkes, D.A. & Kaplan, J.M. Modulation of serotonin-controlled behaviors by Go in Caenorhabditis elegans. Science 267, 1648-1651 (1995).
27. Saitoh, O. et al. RGS7 and RGS8 differentially accelerate G protein-mediated modulation of K+ currents. J. Biol. Chem. 274, 9899-9904 (1999).
28. Hershko, A. & Ciechanover, A. The ubiquitin system. Annu. Rev. Biochem. 67, 425-479 (1998).
29. Rechsteiner, M. PEST sequences are signals for rapid intracellular proteolysis. Semin. Cell Biol. 1, 433-440 (1990).
30. Pulverer, B.J., Kyriakis, J.M., Avruch, J., Nikolakaki, E. & Woodgett, J.R. Phosphorylation of c-jun mediated by MAP kinases. Nature 353, 670-674 (1991).
31. Musti, A.M., Treier, M. & Bohmann, D. Reduced ubiquitin-dependent degradation of c-Jun after phosphorylation by MAP kinases. Science 275, 400-402 (1997).
32. Boone, E., Vandevoorde, V., De Wilde, G. & Haegeman, G. Activation of p42/p44 mitogen-activated protein kinases (MAPK) and p38 MAPK by tumor necrosis factor (TNF) is mediated through the death domain of the 55-kDa TNF receptor. FEBS Lett. 441, 275-280 (1998).
33. Arnould, T. et al. The polycystic kidney disease 1 gene product mediates protein kinase C alpha-dependent and c-Jun N-terminal kinase-dependent activation of the transcription factor AP-1. J. Biol. Chem. 273, 6013-6018 (1998).